Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
View ORCID ProfileYael Gurevich, View ORCID ProfileYoav Ram, View ORCID ProfileLilach Hadany
doi: https://doi.org/10.1101/2021.02.20.21252133
Yael Gurevich
1School of Plant Sciences and Food Security, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Yoav Ram
2School of Zoology, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Lilach Hadany
1School of Plant Sciences and Food Security, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel

Data Availability
The code used to produce the results is available upon request.
Posted February 23, 2021.
Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
Yael Gurevich, Yoav Ram, Lilach Hadany
medRxiv 2021.02.20.21252133; doi: https://doi.org/10.1101/2021.02.20.21252133
Subject Area
Subject Areas
- Addiction Medicine (175)
- Allergy and Immunology (423)
- Anesthesia (97)
- Cardiovascular Medicine (902)
- Dermatology (102)
- Emergency Medicine (257)
- Epidemiology (8810)
- Gastroenterology (405)
- Genetic and Genomic Medicine (1871)
- Geriatric Medicine (179)
- Health Economics (389)
- Health Informatics (1294)
- Health Policy (644)
- Hematology (207)
- HIV/AIDS (397)
- Medical Education (193)
- Medical Ethics (52)
- Nephrology (218)
- Neurology (1770)
- Nursing (105)
- Nutrition (267)
- Oncology (968)
- Ophthalmology (285)
- Orthopedics (107)
- Otolaryngology (177)
- Pain Medicine (118)
- Palliative Medicine (43)
- Pathology (265)
- Pediatrics (560)
- Primary Care Research (221)
- Public and Global Health (3998)
- Radiology and Imaging (657)
- Respiratory Medicine (538)
- Rheumatology (216)
- Sports Medicine (167)
- Surgery (199)
- Toxicology (37)
- Transplantation (107)
- Urology (80)